Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?
Shares of Sun Pharmaceutical Industries tumbled more than 4% to Rs 1,643.60 on Friday after The Economic Times reported that the pharma major has submitted a $12-billion binding offer for Organon & Co., entering the final stage of its most ambitious overseas acquisition bid. The stock emerged as the top loser on the Sensex and…